Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Novartis AG Common Stock (NY:NVS)

159.02 +2.78 (+1.78%)
Streaming Delayed Price Updated: 10:21 AM EDT, Aug 21, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Novartis AG Common Stock

< Previous 1 2
...
22 23 24 25 26 27 28 29 30
...
58 59 Next >
News headline image
How Is The Market Feeling About Novartis? ↗
 
Via Benzinga
News headline image
3 Spectacular High-Yield Dividend Stocks to Buy in November ↗
Income investors should find plenty to like with these stocks. 
Via The Motley Fool
Get Ready for Next Generation of Diabetes, Weight-Management Drugs
Via Investor Brand Network
Get Ready for Next Generation of Diabetes, Weight-Management Drugs
EQNX::TICKER_START (NASDAQ:LEXX),(NYSE:JNJ),(NYSE:SNY),(NASDAQ:AMGN),(NYSE:NVS) EQNX::TICKER_END 
Via FinancialNewsMedia
News headline image
Apple, AMD, Palantir Earnings On Deck This Week As Market Seeks Positive Catalysts In Fed Decision Week ↗
S&P 500 earnings is expected to grow in Q3, reversing a four-quarter slide, as the reporting season enters its third week. 
Via Benzinga
Topics Economy Stocks
News headline image
Novartis Hikes Its Earnings Outlook For The Third Time This Year ↗
The company also beat third-quarter expectations after spinning off its Sandoz unit. 
Via Investor's Business Daily
News headline image
Novartis' Rare Kidney Disease Candidate Aces Late-Stage Study ↗
Novartis AG (NYSE: NVS) released topline results from the interim analysis of the ongoing pivotal Phase 3 ALIGN study of atrasentan in patients with IgA nephropathy (IgAN).  IgAN is a major cause of... 
Via Benzinga
News headline image
Are Your Eyes At Grave Risk? FDA Issues Dangerous Warning Over Popular Drops From CVS, Target, Cardinal Health And More ↗
The U.S. 
Via Benzinga
News headline image
3 No-Brainer Stocks to Buy for Under $100 Right Now ↗
A couple of these stocks might not be available for under $100 for too much longer. 
Via The Motley Fool
News headline image
2 Green Flags and 1 Red Flag for Novartis Stock ↗
The Swiss pharmaceutical company just posted strong Q3 numbers and is going through some big changes. 
Via The Motley Fool
News headline image
7 Undervalued Stocks to Buy Before Everyone Else ↗
Buy these undervalued stocks while they trade at a significant discount compared to their intrinsic valuations. 
Via InvestorPlace
News headline image
Earnings Outlook For Novartis ↗
 
Via Benzinga
News headline image
Sanofi Stock Relative Strength Rating Jumps To 84: One To Watch ↗
Additionally, Sanofi stock has a decent 83 Composite Rating out of 99, and an 80 Earnings Per Share Rating. 
Via Investor's Business Daily
News headline image
Novartis Ag (NVS) Q3 2023 Earnings Call Transcript ↗
NVS earnings call for the period ending September 30, 2023. 
Via The Motley Fool
Topics Earnings
News headline image
Nano Pharmaceutical Market Next Big Move: Major Giants Abbott Laboratories, Bayer AG, Novartis AG, GlaxoSmithKline ↗
According to HTF Market Intelligence, the Global Nano Pharmaceutical market is segmented by Application (Oncology, Cardiovascular/Physiology, Antiinflammatory/Immunology, Neurology, Anti-Infective,... 
Via SBWire
Avenue Z Hires Leading Digital Media and Technology Executive David Corchado to Lead Team in Global Strategy
--News Direct-- 
Via News Direct
News headline image
US Stock Futures Surge Ahead Of Microsoft, Google Earnings: Analyst Says 'Magnificent Seven' Unlikely To See Tesla-Like Volatility After Results ↗
Buoyed by earnings optimism, stocks appear on track for a positive open on Tuesday after the tech-heavy Nasdaq Composite Index snapped a four-day losing streak in the previous session. The uptick in... 
Via Benzinga
Topics Bonds Stocks
News headline image
Novartis Q3: Earnings Beat, Raised Operating Profit Outlook & More ↗
Novartis AG (NYSE: NVS) reported  
Via Benzinga
Topics Earnings
News headline image
Amazon, Alphabet, Meta, Intel Q3 Earnings This Week: Will Mega-Caps Shatter Forecasts And Revive Market? ↗
Factset data indicates that out of the 17% of the S&P 500 companies that have reported so far, 73% have reported positive EPS surprises. 
Via Benzinga
Topics Stocks
News headline image
7 Healthcare Stocks to invest in for a Healthy Future ↗
Considering today's economic uncertainty and market turns, healthcare stocks may be one of the few winning sectors. Here are the winners. 
Via InvestorPlace
News headline image
2 Biotech Stocks That Could Make You Richer ↗
These two well-known drugmakers still have some growth fuel in their seemingly empty tanks. 
Via The Motley Fool
News headline image
3 Unstoppable Stocks to Buy and Hold for Decades ↗
These stocks can be pillars for your long-term portfolio, and investing in all three offers excellent diversification. 
Via The Motley Fool
News headline image
Why Top 1% Biotech MoonLake Just Surged Within Striking Distance Of A Breakout ↗
MoonLake says it's skin-disease treatment showed improved promise in a 24-week testing update. 
Via Investor's Business Daily
News headline image
Weight Loss Drugs Market Size, Share, Growth, Trends, Analysis 2028
Get an extensive Weight Loss Drugs Market analysis of the dominant vendors, their latest products and services, and the competitive landscape of the industry. 
Via SBWire
News headline image
Antiparasitic Drugs Market to See Major Growth by 2023-2030 : Arbor Pharmaceuticals, GlaxoSmithKline, Cipla
Get an extensive Antiparasitic Drugs Market analysis of the dominant vendors, their latest products and services, and the competitive landscape of the industry. 
Via SBWire
News headline image
RayzeBio Is A New Contender in Radiopharmaceutical Arena, Will Attract Prominent Entities: JP Morgan ↗
JP Morgan has initiated coverage on RayzeBio Inc (NASDAQ: RYZB), representing a pure-play opportunity in the radiopharmaceutical space. 
Via Benzinga
News headline image
Cancer Immunotherapies Market Set for More Growth : American Cancer Society, WebMD, Eli Lily and Company
Get an extensive Cancer Immunotherapies Market analysis of the dominant vendors, their latest products and services, and the competitive landscape of the industry. 
Via SBWire
News headline image
AbbVie Stock Moves Higher With Rising Relative Strength ↗
A Relative Strength Rating upgrade for AbbVie shows improving technical performance. Will it continue? 
Via Investor's Business Daily
News headline image
Elsevier Launches New Pharmapendium, Empowering Pharma Companies to Bring Novel Drugs to Market Faster and Increase Success of Regulatory Submissions
London, United Kingdom--(Newsfile Corp. - October 10, 2023) - Elsevier, a global leader in information and data analytics, has launched... 
Via Newsfile
Topics Animal Testing
News headline image
3 Artificial Intelligence Stocks That Could Outperform the ‘Godfather of AI’ ↗
These are the AI stocks to buy and hold for multibagger returns in the next 24 months, as they represent quality growth companies. 
Via InvestorPlace
Topics Artificial Intelligence
< Previous 1 2
...
22 23 24 25 26 27 28 29 30
...
58 59 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.